Home

Precioso cinta Plantación lin et al 2017 bioorganic med chem nf kappa b pirámide Patológico Injusto

Molecules | Free Full-Text | Breakthroughs in Medicinal Chemistry: New  Targets and Mechanisms, New Drugs, New Hopes–5
Molecules | Free Full-Text | Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–5

Protein‐Templated Fragment Ligations—From Molecular Recognition to Drug  Discovery - Jaegle - 2017 - Angewandte Chemie International Edition - Wiley  Online Library
Protein‐Templated Fragment Ligations—From Molecular Recognition to Drug Discovery - Jaegle - 2017 - Angewandte Chemie International Edition - Wiley Online Library

Structural Evolution and Translational Potential for Agonists and  Antagonists of Endosomal Toll-like Receptors | Journal of Medicinal  Chemistry
Structural Evolution and Translational Potential for Agonists and Antagonists of Endosomal Toll-like Receptors | Journal of Medicinal Chemistry

PDF) Synthesis and antibacterial evaluation of macrocyclic diarylheptanoid  derivatives | Aman Singh - Academia.edu
PDF) Synthesis and antibacterial evaluation of macrocyclic diarylheptanoid derivatives | Aman Singh - Academia.edu

Synthetic Approaches to the New Drugs Approved During 2017 | Journal of Medicinal  Chemistry
Synthetic Approaches to the New Drugs Approved During 2017 | Journal of Medicinal Chemistry

Thieno[3,2-b]pyrrole-5-carboxamides as New Reversible Inhibitors of Histone  Lysine Demethylase KDM1A/LSD1. Part 1: High-Throughput Screening and  Preliminary Exploration | Journal of Medicinal Chemistry
Thieno[3,2-b]pyrrole-5-carboxamides as New Reversible Inhibitors of Histone Lysine Demethylase KDM1A/LSD1. Part 1: High-Throughput Screening and Preliminary Exploration | Journal of Medicinal Chemistry

Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes  for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry

The Cravatt Lab
The Cravatt Lab

Molecules | Free Full-Text | Anti-Cancer Potential of Synthetic Oleanolic  Acid Derivatives and Their Conjugates with NSAIDs
Molecules | Free Full-Text | Anti-Cancer Potential of Synthetic Oleanolic Acid Derivatives and Their Conjugates with NSAIDs

4‐(Di‐/Trifluoromethyl)‐2‐heterabicyclo[2.1.1]hexanes: Advanced Fluorinated  Phenyl Isosteres and Proline analogues - Homon - 2021 - European Journal of  Organic Chemistry - Wiley Online Library
4‐(Di‐/Trifluoromethyl)‐2‐heterabicyclo[2.1.1]hexanes: Advanced Fluorinated Phenyl Isosteres and Proline analogues - Homon - 2021 - European Journal of Organic Chemistry - Wiley Online Library

Discovery and Optimization of Boronic Acid Based Inhibitors of Autotaxin |  Journal of Medicinal Chemistry
Discovery and Optimization of Boronic Acid Based Inhibitors of Autotaxin | Journal of Medicinal Chemistry

Medicinal chemistry of indole derivatives: Current to future therapeutic  prospectives - ScienceDirect
Medicinal chemistry of indole derivatives: Current to future therapeutic prospectives - ScienceDirect

Morpholine as ubiquitous pharmacophore in medicinal chemistry: Deep insight  into the structure-activity relationship (SAR) - ScienceDirect
Morpholine as ubiquitous pharmacophore in medicinal chemistry: Deep insight into the structure-activity relationship (SAR) - ScienceDirect

Recent Advances in the Medicinal Chemistry of Farnesoid X Receptor |  Journal of Medicinal Chemistry
Recent Advances in the Medicinal Chemistry of Farnesoid X Receptor | Journal of Medicinal Chemistry

Molecules | Free Full-Text | Breakthroughs in Medicinal Chemistry: New  Targets and Mechanisms, New Drugs, New Hopes–7
Molecules | Free Full-Text | Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–7

Molecules | Free Full-Text | 2-Phenethylamines in Medicinal Chemistry: A  Review
Molecules | Free Full-Text | 2-Phenethylamines in Medicinal Chemistry: A Review

Design of Novel 3-Pyrimidinylazaindole CDK2/9 Inhibitors with Potent In  Vitro and In Vivo Antitumor Efficacy in a Triple-Negative Breast Cancer  Model | Journal of Medicinal Chemistry
Design of Novel 3-Pyrimidinylazaindole CDK2/9 Inhibitors with Potent In Vitro and In Vivo Antitumor Efficacy in a Triple-Negative Breast Cancer Model | Journal of Medicinal Chemistry

Are We Opening the Door to a New Era of Medicinal Chemistry or Being  Collapsed to a Chemical Singularity? | Journal of Medicinal Chemistry
Are We Opening the Door to a New Era of Medicinal Chemistry or Being Collapsed to a Chemical Singularity? | Journal of Medicinal Chemistry

Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A  Medicinal Chemistry Perspective | Journal of Medicinal Chemistry
Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective | Journal of Medicinal Chemistry

Scaffold Diversity Inspired by the Natural Product Evodiamine: Discovery of  Highly Potent and Multitargeting Antitumor Agents | Journal of Medicinal  Chemistry
Scaffold Diversity Inspired by the Natural Product Evodiamine: Discovery of Highly Potent and Multitargeting Antitumor Agents | Journal of Medicinal Chemistry

Drug Discovery: Covalent Bonds Between Small Molecules & Proteins
Drug Discovery: Covalent Bonds Between Small Molecules & Proteins

Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase  Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory  Diseases | Journal of Medicinal Chemistry
Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases | Journal of Medicinal Chemistry

Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors  That Have High Selectivity over Phosphoinositide-3-kinase (PI3K) | Journal  of Medicinal Chemistry
Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K) | Journal of Medicinal Chemistry

Molecules | Free Full-Text | Chlojaponilactone B Attenuates  Lipopolysaccharide-Induced Inflammatory Responses by Suppressing  TLR4-Mediated ROS Generation and NF-κB Signaling Pathway
Molecules | Free Full-Text | Chlojaponilactone B Attenuates Lipopolysaccharide-Induced Inflammatory Responses by Suppressing TLR4-Mediated ROS Generation and NF-κB Signaling Pathway